¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"energy fluence rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • dose rate
    1. ¼±·®·ü 2. Åõ¿©·®
  • dose rate effect
    ¼±·®·üÈ¿°ú
  • dose rate meter
    ¼±·®·ü°è, ¼±·®·üÃøÁ¤±â
  • exponential growth rate
    Áö¼öÁõ½Ä·ü, Áö¼ö¼ºÀå·ü
  • exposure rate
    ³ëÃâ·ü, ÇÇÆø·ü
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • early neonatal mortality rate
    Á¶±â½Å»ý¾Æ»ç¸Á·ü
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • fatality rate
    Ä¡¸í·ü
  • fertility rate
    »ý½Ä·ü
  • fetal death rate
    žƻç¸Á·ü
  • fetal heart rate
    žƽɹڼö
  • filtration rate
    ¿©°úºñ, ¿©°úÀ², ¿©°ú¼Óµµ
  • five-year survival rate
    ¿À³â»ýÁ¸À²
  • fixed rate pacemaker
    °íÁ¤¼Óµµ¹Úµ¿Á¶À²±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cumulative death rate
    ´©Àû»ç¸Á·ü
  • cumulative incidence rate
    ´©Àû¹ß»ý·ü
  • cumulative survival rate
    ´©Àû»ýÁ¸À²
  • cure rate
    Ä¡À¯À²
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • growth rate constant
    Áõ½Ä·ü»ó¼ö
  • kerma rate constant
    Ä¿¸¶À²»ó¼ö
  • mortality rate curve
    »ç¸Á·ü°î¼±
  • rate constant
    ¼Óµµ»ó¼ö
  • death rate
    »ç¸Á·ü
  • defect rate
    °áÇÔ·ü
  • diffusion rate
    È®»êÀ²
  • disability rate
    Àå¾ÖÀ²
  • disappearance rate
    ¼Ò½Ç·ü
  • divorce rate
    ÀÌÈ¥À²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • prevalence [rate]
    À¯º´·ü
  • prevalence rate
    À¯º´·ü(ËôËÓËô).
  • production rate
    »ý»êÀ²
  • puerperal death rate
    »ê¿å»ç¸Á·ü (ÊÙË×ËÎËô).
  • puerperal death rate
    »êÈÄ»ç¸Á·ü,»ê¿å»ç¸Á·ü (¡­ÞÝØÌëÒ)
  • pulse rate
    ÆÞ½ºÀ²
  • pulse repetition rate
    ÆÞ½º ¹Ýº¹À²
  • rate
    ¼Óµµ
  • rate dependent bundle branch block
    ½É¹Ú¼öÀÇÁ¸¼º °¢Â÷´Ü.
  • rate limiting
    ¼ÓµµÁ¦ÇÑÀÇ.
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò(áÜöôðàï½ý£áÈ).
  • rate limiting reaction
    ¼ÓµµÁ¦ÇѹÝÀÀ.
  • rate meter
    °è¼öÀ²°è(ͪâ¦ëÒͪ).
  • rate of flow
    ¹æ¼ö·ù·®, ¹æ¼ö»ý»ê·®
  • rate of hardening
    °æÈ­¼Óµµ(ÌãûùáÜöô).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • most probable energy
    ÃÖÀ¯·Â¿¡³ÊÁö
  • nerve energy =nurin
    ½Å°æ¿¡³ÊÁö.
  • nuclear energy
    ÇÙ(ú·)¿¡³ÊÁö.
  • potential energy
    À§Ä¡(êÈöÇ)¿¡³ÊÁö.
  • potential energy
    ÀüÀ§¿¡³ÊÁö
  • pressure energy
    ¾Ð·Â (äâÕô) ¿¡³ÊÁö
  • protein-energy malnutrition
    ´Ü¹é(Áú)¿¡³ÊÁö¿µ¾ç½ÇÁ¶(Áõ)(¡­ç½å×ã÷ðà(ñø))
  • psychic energy
    Á¤½Å¿¡³ÊÁö.
  • radiant energy
    º¹»ç<¹æ»ç>¿¡³ÊÁö.(¹æ»ç¼±)¹æ»ç¿¡³ÊÁö.
  • radiant energy
    ¹æ»ç¿¡³ÊÁö
  • radiant energy absorption
    º¹»ç(¹æ»ç)¿¡³ÊÁöÈí¼ö
  • radiation energy
    ¹æ»ç¼±¿¡³ÊÁö
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
  • resonance energy
    °ø¸í¿¡³ÊÁö.
  • rest energy
    ÀÏÁ¤¿¡³ÊÁö.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MHR major histocompatibility region; malignant hyperthermia resistance; maternal heart rate; maximal hea...
MMFR maximum midexpiratory flow rate; maximal midflow rate
MMR mass miniature radiography; masseter muscle rigidity; maternal mortality rate; measles-mumps-rubella...
MPR mannose 6-phosphate receptor; marrow production rate; massive preretinal retraction; maximum pulse r...
MRR marrow release rate; maximum relation rate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
EI Energy Intake
EC Energy charge
EDX Energy dispersive X-ray analysis
EDX Energy dispersive X-ray microanalysis
EDAX Energy dispersive analysis of X-rays
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum expiratory flow rate
    ÃÖ´ë È£±â À¯·®·ü
  • maximum mid-expiratory flow rate
    ÃÖ´ë Áß°£ È£±â À¯Ãâ ¼Óµµ
  • mean airflow rate
    ¹ß¼º½Ã È£±â·ùÀ²
  • metabolic rate
    ´ë»çÀ²
  • mortality rate
    »ç¸Á·ü
  • mutation rate
    º¯ÀÌÀ², µ¹¿¬º¯ÀÌÀ²
  • neonatal mortality rate
    ½Å»ý¾Æ »ç¸Á·ü
  • operative mortality rate
    ¼ö¼ú »ç¸Á·ü
  • overall rate
    ÃÑüÀû ºñÀ²
  • peak flow rate
    ÃÖ´ë À¯¼Ó, ÃÖ°í À¯¼Ó
  • prevalance rate
    À¯º´À²
  • prevalence rate
    À¯º´·ü
  • processing rate
    ½Ã¼ú È¿À²
  • rate dependent bundle branch block
    ½É¹Ú ¼ö ÀÇÁ¸¼º °¢ Â÷´Ü
  • rate of ablation
    Á¦°ÅÀ²
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
kinetic energy <chemistry> Energy due to the motion of an object
(09 Jan 1998)
unit of energy CGS system: erg, joule, MKS system: newton-meter (joule), FPS system: foot-poundal,gravitational unit: gram-centimeter, gram-meter, kilogram-meter, foot-pound,SI: joule.
(05 Mar 2000)
fluorescence energy transfer <technique> Transfer of energy from one fluorochrome to another. The emission wavelength of the fluorochrome excited by the incident light must approximately match the excitation wavelength of the second fluorochrome.
If light at the second emission wavelength is detected, it implies that the two fluorochromes were physically within a few nanometres. Used as a technique to probe protein or cell interactions.
(25 Jun 1999)
latent energy <chemistry> Energy due to position, it is stored energy which can be used to do work.
(09 Jan 1998)
free energy A thermodynamic term used to describe the energy that may be extracted from a system at constant temperature and pressure. In biological systems the most important relationship is: _G = RTln(Keq), where Keq is an equilibrium constant.
(18 Nov 1997)
fusion energy <chemistry, radiobiology> The binding energy of a nucleus is the minimum energy required to dissociate it into its component neutrons and protons. Neutron or proton binding energies are those required to remove a neutron or proton, respectively, from a nucleus. Electron binding energy is that required to remove an electron from an atom or a molecule.
(16 Dec 1997)
linear energy transfer <radiobiology> Average amount of energy lost per unit of particle track length and expressed in keV um-1.
Acronym: LET
(16 Dec 1997)
abortion rate The number of abortions per 1000 terminated pregnancies during a given period of time.
(05 Mar 2000)
age-specific rate A rate for a specified age group, in which the numerator and denominator refer to the same age group.
(05 Mar 2000)
attack rate A cumulative incidence rate used for particular groups observed for limited periods under special circumstances, such as during an epidemic.
(05 Mar 2000)
average flow rate <physiology> The flow rate determined by dividing the total volume passed in a time period divided by the time period, usually quoted in mls per minute.
(05 Mar 2000)
backup rate A utility charge for providing occasional electricity service to replace on-site generation.
(05 Dec 1998)
basal metabolic rate <biochemistry, biology> The metabolic rate as measured under basal conditions: 12 hours after eating, after a restful sleep, no exercise or activity preceding test, elimination of emotional excitement and occurring in a comfortable temperature.
Acronym: BMR
(15 Nov 1997)
baseline foetal heart rate <paediatrics> The average heart rate for a particular foetus during the diastolic phase of uterine contractions.
(05 Mar 2000)
baseline variability of foetal heart rate The beat-to-beat changes in foetal heart rate as recorded on a graph.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • rate
    ºñÀ²;¿ä±Ý;½Ã¼¼;°¡°Ý;Æò°¡;¼Óµµ;Áøµµ;ÇÏ·çÀÇ ¿ÀÂ÷(½Ã°èÀÇ);¼¼±Ý;Áö¹æ¼¼;µî±Þ(¹è.¼±¿øÀÇ)...µî;Á¾·ù;Æò°¡ÇÏ´Ù;¾î¸²Àâ´Ù;...À¸·Î ¾Ë´Ù;À̶ó°í »ý°¢ÇÏ´Ù;(°ú¼¼¸¦ ¸ñÀûÀ¸·Î)...À» Æò°¡ÇÏ´Ù;...¿¡°Ô Áö¹æ¼¼¸¦ °úÇÏ´Ù;(¼±¿ø.¼±¹ÚÀÇ)µî±ÞÀ» Á¤ÇÏ´Ù;±Ô°ÝÀ» Á¤ÇÏ´Ù;(±â°èÀÇ)¿ÀÂ÷¸¦ Ãø
  • rate base
    (ÀâÁöÀÇ)º¸Áõ ºÎ¼ö(À̸¦ ¹ÙÅÁÀ¸·Î ±¤°í¿ä±ÝÀÌ Á¤ÇØÁü)
  • rate card
    ±¤°í ¿äÀ²Ç¥(±¤°í ¿ä±Ý.°ÔÀç ȸ¼ö.¿ø°í ¸¶°¨ÀÏ µîÀ» ¸í½ÃÇÑ Ç¥)
  • rate meter
    (°è¼ö±âÀÇ)°è¼öÀ²°è
  • rediscount rate
    (¾îÀ½ÀÇ)ÀçÇÒÀÎÀ²
  • second rate
    2·ùÀÇ;2µîǰ;...¸¸ ¸øÇÑ
  • second rate
    2·ùÀÇ;¿­µîÇÑ;Æò¹üÇÑ
  • third rate
    3µîÀÇ;¿­µîÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á